Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms

Thrombosis Research
Jérôme DucheminJean-François Abgrall

Abstract

Microparticles (MPs) are membrane fragments ranging in size from 0.1 to 1 microm, and are considered as biomarkers reflecting prothrombotic state in many clinical diseases. The clinical course of myeloproliferative neoplasms (MPN) being frequently complicated by thrombotic events, we determined the MPs activity, i.e. circulating procoagulant activity (CPA), in polycythemia vera (PV) and essential thrombocythemia (ET) patients. To evaluate the influence of MPs on the coagulation, a thrombin generation test was realized in the absence and presence of thrombomodulin (TM). Compared with controls, patients had a higher CPA (24.0+/-9.0 vs 10.6+/-4.4 nM, p<0.001), which was associated with a lower inhibition of the thrombin generation in the presence of TM (20.1+/-9.5% vs 28.4+/-11.8%, p<0.001), compatible with a low sensitivity to TM. This sensitivity was influenced by the JAK2V617F mutational status, homozygous patients presenting the lowest inhibition rate of the thrombin generation. Filtration through a 0.22 microm membrane increased the sensitivity to TM in plasma, suggesting an influence of MPs in the "TM-resistance" observed in patients. Moreover, MPN patients receiving antiplatelet and/or cytoreductive therapies, our study sug...Continue Reading

References

Dec 7, 1983·Biochimica Et Biophysica Acta·E M BeversR F Zwaal
Jul 11, 2003·Pathophysiology of Haemostasis and Thrombosis·H Coenraad HemkerSuzette Béguin
Mar 8, 2005·Journal of Thrombosis and Haemostasis : JTH·G SarigN Haim
Apr 29, 2005·The New England Journal of Medicine·Robert KralovicsRadek C Skoda
Jun 20, 2006·Best Practice & Research. Clinical Haematology·Raffaele LandolfiLinda Novarese
Nov 16, 2006·Blood·Raffaele LandolfiUNKNOWN European Collaboration on Low-Dose Aspirin in Polycythemia Vera (ECLAP)
Nov 23, 2006·Blood Reviews·Andrea PiccinOwen P Smith
Aug 1, 2008·Thrombosis Research·Shosaku NomuraYasuo Ikeda
Aug 12, 2008·Thrombosis Research·Françoise Dignat George
Jan 30, 2009·Vox Sanguinis·A S LawrieP Harrison
Mar 12, 2009·Thrombosis and Haemostasis·Laurent BurnierAnne Angelillo-Scherrer

❮ Previous
Next ❯

Citations

Sep 14, 2014·Current Neurology and Neuroscience Reports·Andrea ArtoniIda Martinelli
Jul 17, 2013·British Journal of Haematology·Mallika SekharAndrew K Burroughs
Feb 24, 2015·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Micah J Mooberry, Nigel S Key
Jul 5, 2013·Blood·Tiziano BarbuiAnna Falanga
Jul 22, 2014·Journal of Extracellular Vesicles·Céline BouvyJean-Michel Dogné
Mar 15, 2018·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Hui Y LimPrahlad Ho
Apr 23, 2013·American Journal of Physiology. Heart and Circulatory Physiology·Fiona A MartinPhilip M Cummins
Sep 19, 2019·Médecine sciences : M/S·Alexandre Guy, Chloé James
Feb 12, 2020·The Journal of Clinical Investigation·Johanne PoissonPierre-Emmanuel Rautou
May 31, 2020·Molecular Biology Reports·Mohsen MalekniaNajmaldin Saki
Feb 2, 2017·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Romeo-Gabriel Mihaila
May 16, 2019·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Fatma Demir YenigürbüzHale Ören
Apr 2, 2015·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Jarmila KissovaMiroslav Penka
Apr 4, 2021·Genes·Dorian ForteLucia Catani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.